
Elan offers special dividend to fend off Royalty
DUBLIN/NEW YORK (Reuters) - Irish drugmaker Elan has sweetened the terms on offer to shareholders under a $3.25 billion disposal plan to try to stave off an approach for the...
eNewspaper
Trending:









